RT @GEHealthcare: Is elevated troponin still a reliable biomarker in the COVID-19 era? Now, with the known cardiac effects of COVID-19, there is more empirical evidence to suggest it isn't as effective of a barometer for ACS as was once believed. https://t.co/Y0psA3sgdJ #cardiotwitter https://t.co/KAHTLSeOGh
Is elevated troponin still a reliable biomarker in the COVID-19 era? Now, with the known cardiac effects of COVID-19, there is more empirical evidence to suggest it isn't as effective of a barometer for ACS as was once believed. https://t.co/Y0psA3sgdJ #cardiotwitter pic.twitter.com/KAHTLSeOGh
— GE Healthcare (@GEHealthcare) July 15, 2020
from Twitter https://twitter.com/GastonR48222321
July 17, 2020 at 12:53PM
Comentarios
Publicar un comentario